Anil K. Sood

Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

M. Shahin, Wei Hu, J. Fiorica, 2012, Gynecologic oncology.

Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer.

A. Jazaeri, T. Bathala, D. Ganeshan, 2023, Cancer.

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study.

A. Godwin, A. Sood, C. Drescher, 2012, Gynecologic oncology.